2016

Guest Post: Translating the Miracle of Marrakesh into Concrete Action – the Journey So Far

/ By / Copyright

As recently announced, we have opened our 4th annual SpicyIP Fellowship series and are now accepting applications. [Click here to see how to apply]. Our first application this year comes from Rahul Bajaj, a very enterprising 4th year student from the University of Nagpur, where he looks at the current status of the Marrakesh Treaty. The Marrakesh Treaty adopted back in July, 2013 by 64 countries, and at the time hailed as a significant step towards increasing accessibility for the print-disabled, has […]

Guest Post: Translating the Miracle of Marrakesh into Concrete Action – the Journey So Far Read More »

SpicyIP Weekly Review ( 17th January – 23rd January)

/ By / Others

Our SpicyIP Highlight of the Week was definitely Balaji’s post breaking the news of the IPO’s rejection of Lee Pharma’s application for a Compulsory License against AstraZeneca’s patent for the anti-diabetic drug Saxagliptin (see here). He notes that the rejection signals the end of the third compulsory license application in India, after Natco v. Bayer and BDR v. BMS. He goes on to discuss the details of the order in his next post. Next, Shruthi announced the commencement of the

SpicyIP Weekly Review ( 17th January – 23rd January) Read More »

Examining the rejection of Lee’s Saxagliptin CL application

/ By / Patent

Last July, an anonymous tip-off led us to Lee Pharma’s application for a Compulsory License against AstraZeneca’s Saxagliptin patent (IN206543). In that post, Swaraj and I covered the merits of Lee’s application extensively, before concluding that it was unlikely to succeed. In August, the IPO issued a prima facie finding rejecting the application under Rule 97(1) of the Patent Rules, 2003. Lee’s counsel requested a hearing, and were granted one on 15 December 2015 along with supplementary submissions on 29

Examining the rejection of Lee’s Saxagliptin CL application Read More »

SpicyIP Tidbit: IICA announces Courses in Competition Law

/ By / Competition Law, Others, Sponsored

We’re very happy to announce that the Indian Institute of Corporate Affairs (IICA) has opened applications for two of its courses on Competition Law, comprising strong IPR modules. Read on for more details of the courses: Certificate Course in Competition Law (CCCL) Duration: 3 months (February – April 2016) The CCCL has been designed for professionals, who wish to fully grasp the impact of competition law on business strategy, and development competence on competition law compliance. Advanced Professional Course (APC)

SpicyIP Tidbit: IICA announces Courses in Competition Law Read More »

Breaking news: IPO rejects Saxagliptin CL application

/ By / Patent

We’ve received news that the IPO has rejected Lee Pharma’s application for a Compulsory License against AstraZeneca’s patent for the anti-diabetic drug Saxagliptin. We’d covered the story earlier when the application was first filed last year, and again when the Controller of Patents issued a prima facie finding rejecting it in August. The rejection comes vide an order dated 19 January 2016 from the IPO, which can be found here. I will be posting a detailed analysis of the order (which, like

Breaking news: IPO rejects Saxagliptin CL application Read More »

SpicyIP Event: 2016 ITechLaw India Conference

/ By / Event, Sponsored

We are very happy to announce that registrations are open for the ITechLaw India Conference, scheduled to be held in Bangalore from January 27-29, 2016.   SpicyIP readers also get a special discounted ‘Member / Affiliate’ registration fee! For any questions regarding registration, contact [email protected].  Read on for more details from the ITechLaw team: Register Today 2016 ITechLaw India Conference “How Technology is Changing the Digital Life, Lifestyle Business and the Underworld” The Taj West End, Bangalore, India | 27-29 January 2016 Register Today!

SpicyIP Event: 2016 ITechLaw India Conference Read More »

SpicyIP Tidbit: FICCI’s Online Certificate Courses on IPR- Announcement for Registration

/ By / Others, Sponsored

We are happy to announce that the Federation of Indian Chambers of Commerce and Industry (FICCI) has been organising two online certificate courses on IPR, which might be of interest to our readers, for the past 5 years. Please note that registrations for these courses have already started. Online Certificate Course on Competition Law & Intellectual Property Rights (IPComp) Online Certificate Course on Intellectual Property Rights(IP) Read on for more details about these courses: Online Certificate Course on Competition Law

SpicyIP Tidbit: FICCI’s Online Certificate Courses on IPR- Announcement for Registration Read More »

SpicyIP Weekly Review (4-17 January, 2016)

/ By / Others

Highlight of the Fortnight The highlight of the past couple of weeks has to be Prof. Basheer’s post on copyfraud and collecting societies. He links the “IP excesses” committed by IPRS and PPL to the concept of “copyfraud”, or the serving of false and frivolous copyright infringement notices indiscriminately. After noting that the long arm of the law has nearly caught up with IPRS and PPL, he goes on to suggest that the way forward would be for a strict

SpicyIP Weekly Review (4-17 January, 2016) Read More »

Guest Post: “Martin Shkreli: The Man of the (Pharma) Year 2015”

/ By / Drug Regulation, Patent

I’m very happy to bring you a guest post by a dear friend of the blog, Mr Zakir Thomas, on the entrepreneur who ironically may have managed to bring more scrutiny on the out-of-control circus that drug pricing is, than health activists have managed in years of trying! Yes, we’re talking about the infamous Martin Shkreli. Readers may remember that I had voiced a similar sentiment in my piece titled ‘The Good that Martin Shkreli has done“. In this piece, Zakir Thomas takes up

Guest Post: “Martin Shkreli: The Man of the (Pharma) Year 2015” Read More »

No rockin’ around this Christmas tree: IPRS v. Harsh Vardhan Samor

/ By / Copyright

The archives of this blog are punctuated with disturbing regularity by the notorious misadventures of an organisation that calls itself the Indian Performing Rights Society. In the latest in that series, we bring to you an order from the Bombay High Court in IPRS v. Harsh Vardhan Samor. Delivered ex parte on 22 December 2015, it restrains the owners of a Mumbai restaurant, He Said She Said, from performing musical works in IPRS’s repertoire at its premises, including at its

No rockin’ around this Christmas tree: IPRS v. Harsh Vardhan Samor Read More »

Scroll to Top